Amitriptyline for agitation in head injury

Area of Science:

• Neuroscience
• Psychiatry
• Traumatology

Background:

• Agitated behavior is a common sequela of traumatic closed head injury (TCHI).
• Standard behavioral interventions and psychopharmacological treatments for TCHI-related agitation often prove unsuccessful or cause detrimental sedation.
• Frontal lobe damage specifically can lead to severe agitation and behavioral disturbances.

Observation:

• A 32-year-old female patient experienced severe agitation following a frontal lobe TCHI.
• Conservative behavioral management strategies failed to alleviate her symptoms.
• A therapeutic trial of amitriptyline was initiated to address the persistent agitation.

Findings:

• Within two weeks of amitriptyline treatment, the patient exhibited a significant reduction in aggressive outbursts.
• Her attention span showed marked improvement during the treatment period.
• Serial neuropsychological assessments confirmed the preservation of cognitive indices and demonstrated improvement in Trailmaking task performance.

Implications:

• This case suggests amitriptyline may be a viable therapeutic option for managing agitation in patients with frontal lobe damage.
• Tricyclic antidepressants like amitriptyline could potentially alleviate agitation without hindering cognitive recovery.
• Further research into the efficacy of tricyclic antidepressants for TBI-related agitation is warranted.